2023 Annual Meeting | C144 - Epilepsy and Neuroimmunology

��ɫ��

2023 Annual Meeting | C144 - Epilepsy and Neuroimmunology

Date Tuesday 04/25/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kelsey M. Smith, MD

Topic(s) Autoimmune Neurology, Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants will get updates regarding epilepsy and neuroimmunology and learn to describe the electroclinical features of seizures associated with autoimmune encephalitis and autoimmune associated epilepsy, focusing on seizures associated with LGI1, NMDA-R, and GAD65 antibodies; summarize data about treatment of these disorders; and discuss updated treatment strategies for new onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES).

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 03:40 PM EST	Introduction	Introduction and Welcome Kelsey M. Smith, MD
03:40 PM - 04:10 PM EST	Speaker	LGI1 and NMDAR Antibody Encephalitis: Clinical Presentation, Seizure Semiology, and Treatment Strategies Kelsey M. Smith, MD
04:10 PM - 04:40 PM EST	Speaker	GAD65 Antibody Associated Epilepsy: Clinical Presentation and Treatment Challenges Christian Bien, MD
04:40 PM - 05:10 PM EST	Speaker	New Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-related Epilepsy Syndrome (FIRES): Current Treatment Strategies Coral M. Stredny, MD
05:10 PM - 05:30 PM EST	Discussion	Questions, Answers, and Panel Discussion Kelsey M. Smith, MD, Christian Bien, MD, Coral M. Stredny, MD

Faculty Disclosures
Christian Bien, MD	Dr. Bien has nothing to disclose.
Kelsey M. Smith, MD	The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Coral M. Stredny, MD	Dr. Stredny has stock in Proctor and Gamble. The institution of Dr. Stredny has received research support from Pediatric Epilepsy Research Foundation.

��ɫ����

��ɫ����

��ɫ��

��ɫ��